1. AB0244 Development of an adjusted multi-biomarker disease activity (MBDA) score for rheumatoid arthritis (RA) that accounts for age, sex and adiposity, with subsequent evaluation of ability to predict risk for radiographic damage. (12th June 2018) Authors: Curtis, J.R.; Flake, D.D.; Weinblatt, M.; Shadick, N.A.; Østergaard, M.; Hetland, M.L.; Heegaard Brahe, C.; Hwang, Y.G.; Furst, D.E.; Strand, V.; Etzel, C.J.; Pappas, D.; Wang, X.; Hwang, C.C.; Sasso, E.H.; Gutin, A.; Hitraya, E.; Lanchbury, J.S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0376 Neither RA Disease Activity nor TNFI Increase the Incidence of Lymphoma in A Large, US RA Registry. (10th June 2014) Authors: Furst, D.E.; Cox, V.; Etzel, C.J.; Greenberg, J.D.; Collier, D. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0378 Anti-Drug Antibody (ADAB) Differentially Affect Response among Specific TNFI and Also among Diseases: an SLR and Meta-Analysis. (10th June 2014) Authors: Borazan, N.; Thomas, S.; Barroso, N.; Duan, L.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0446 Treatment Effects and Minimal Clinically Important Differences in Patient-Reported Outcomes Following Treatment and Withdrawal of Abatacept, Methotrexate Or Combination Therapy in Patients with Early Rheumatoid Arthritis. (9th June 2015) Authors: Furst, D.E.; Bykerk, V.P.; Burmester, G.R.; Combe, B.G.; Huizinga, T.W.J.; Alemao, E.; Wong, D.A.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0455 Disease duration, but not rheumatoid factor status, impacts clinical response in adalimumab-treated rheumatoid arthritis patients with an inadequate response to standard dmard therapy: Subgroup analysis of the DE020 continuation trial. (23rd January 2014) Authors: Furst, D.E.; Weinblatt, M.E.; Kavanaugh, A.; Birbara, C.; Kupper, H.; Obermeyer, K.; Faccin, F. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0456 Improvement and maintenance of hemoglobin levels among rheumatoid arthritis, psoriatic arthritis & ankylosing spondylitis patients with anemia of inflammation after treatment with golimumab: 3 yr pooled analysis from golimumab rheumatology clinical program. (23rd January 2014) Authors: Furst, D.E.; Gathany, T.A.; Kay, J.; Wasko, M.C.; Keystone, E.; Kavanaugh, A.; Deodhar, A.; Murphy, F.; Han, C.; Doyle, M.K. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0479 Patient outcomes following 10 years of treatment with adalimumab in the DE020 roll-over trial. (23rd January 2014) Authors: Weinblatt, M.E.; Furst, D.E.; Kavanaugh, A.; Faccin, F.; Kupper, H.; Obermeyer, K.; Birbara, C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0480 Certolizumab pegol plus methotrexate is similarly effective in active rheumatoid arthritis regardless of prior TNF inhibitor use: Analysis of the doseflex PHASE IIIB study. (23rd January 2014) Authors: Schiff, M.; Davies, O.; Bennett, B.; Luijtens, K.; Furst, D.E. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB0591 Nailfold Videocapillaroscopy May Not Reflect Change of Digital Ulcers Status in A Short Term Evaluation of Systemic Sclerosis Patients. (15th July 2016) Authors: Bruni, C.; Ngcozana, T.; Braschi, F.; Barskova, T.; Guiducci, S.; Bellando-Randone, S.; Tofani, L.; Denton, C.P.; Furst, D.E.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0724 Biomarkers Sensitive to Change in Patients with Systemic Sclerosis – a Systematic Review. (9th June 2015) Authors: Toniolo, M.; Dobrota, R.; Moinzadeh, P.; Ogawa, R.; Furst, D.E.; Denton, C.P.; Khanna, D.; Distler, O. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗